3D bioprinted scaffolds are one of the most novel and promising tissue regenerative therapeutics currently in development (e.g. to repair damaged cardiac tissue). Validation of correct scaffold placement and retention post-implantation is essential, but it is challenging to visualize scaffolds in-vivo given their similar material properties to native tissue. In this study, a T1-reducing contrast agent, MnPNH2, was utilized to create an MR-trackable, bioprinted scaffold. In-vitro and in-vivo results confirmed the novel scaffold provided an environment conducive to cell growth and offered significant bright contrast for post-implantation scaffold monitoring in rats.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords